Company Overview of Plectix BioSystems, Inc.
Plectix BioSystems, Inc. engages in the research and development of approaches to the protein transformations and interactions that underpin cellular signaling networks. The company offers Cellucidate, a Web-based platform and language system that helps academic and drug-discovery researchers to represent pathways and study cell signaling systems, as well as develops approaches for drug discovery and development. Its approaches enable biologists to develop signaling processes and design interventions based on molecular mechanisms. The company was founded in 2004 and is based in Somerville, Massachusetts.
20 Holland Street
Somerville, MA 02144
Founded in 2004
Key Executives for Plectix BioSystems, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Plectix BioSystems, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.